This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A

Targeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma.

Related Keywords

New York ,United States ,Dan Lyons ,Bristol Rayzebio ,Andrew Tsai ,Bristol Myers Squibb ,Piper Sandler Tenthoff ,Jeff Jones ,Gregory Renza ,Janus Henderson Lyons ,Piper Sandler ,Eli Lilly ,William Blair ,Edward Tenthoff ,Matt Phipps ,Novartis ,Fusion Pharmaceuticals ,Astrazeneca ,Globaldata Pharma Intelligence Center Deals Database ,Wall Street ,Mariana Oncology ,Point Biopharma ,Aktis Oncology ,Janus Henderson ,Myers Squibb ,Pharma Intelligence Center Deals ,